Eyesvision Corp. (KOSDAQ:031310)
1,008.00
+146.00 (16.94%)
At close: Jun 29, 2026
Eyesvision Revenue
Eyesvision had revenue of 46.73B KRW in the quarter ending March 31, 2026, with 29.67% growth. This brings the company's revenue in the last twelve months to 205.07B, up 17.93% year-over-year. In the year 2025, Eyesvision had annual revenue of 194.38B with 6.34% growth.
Revenue (ttm)
205.07B
Revenue Growth
+17.93%
P/S Ratio
0.14
Revenue / Employee
3.60B
Employees
57
Market Cap
29.07B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 194.38B | 11.59B | 6.34% |
| Dec 31, 2024 | 182.78B | -8.19B | -4.29% |
| Dec 31, 2023 | 190.97B | -653.13M | -0.34% |
| Dec 31, 2022 | 191.62B | 46.60B | 32.13% |
| Dec 31, 2021 | 145.03B | 9.76B | 7.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Austem Company | 138.44B |
| GH Advanced Materials | 87.09B |
| Kyung Nam Pharm | 56.18B |
| New Kids On | 47.64B |
| MOBIRIX | 42.98B |
| TELCON RF PHARMACEUTICAL. | 42.88B |
| Uracle | 40.80B |
| MICUBE Solution | 24.01B |